Effect of Benzalkonium Chloride on Percutaneous Absoption of Antisense Phosphorothioate Oligonucleotides

  • Lee, Young-Mi (College of Pharmacy and Medicinal Resource Research Center, Wonkwang University) ;
  • Lee, Sung-Hee (College of Pharmacy and Medicinal Resource Research Center, Wonkwang University) ;
  • Ko, Geon-Il (College of Pharmacy and Medicinal Resource Research Center, Wonkwang University) ;
  • Kim, Jae-Baek (College of Pharmacy and Medicinal Resource Research Center, Wonkwang University) ;
  • Sohn, Dong-Hwan (College of Pharmacy and Medicinal Resource Research Center, Wonkwang University)
  • Published : 1996.12.01

Abstract

The effect of benzalkonium chloride on skin permeability of partially modified antisense phosphorothioate oligonucleotides (PS-ODN), which are designed as scar formation inhibitor, was investigated using Franz Diffusion Cell. When the concentration ratio of PS-ODN-quarternary ammonium salt complex is more than 1:100, the apparent partition coefficient (APC) of each complex was increased in the following order; tetraphenyl phosphonium chloride (TPP) < cetyltrimethyl ammonium bromide(CTAB) < benzalkonium chloride (BZ). The permeability of PS-ODN through the rat skin increased in the presence of BZ. The fluxs of PS-ODN with BZ were increased by addition of Pluronic F 68 or Triton X-100 to phosphate buffered saline (PBS), respectively. When the mole ratio of PS-ODN to BZ is 1:10, the fluxs penetrated of PS-ODN with BZ was greatest. The increase of the permeability in the presence of BZ might be due to the formation of lipophilic ion-pair complex between PS-ODN and BZ. By regulation of mole ratio of PS-ODN to BZ, the development of topical dosage forms using PS-ODN as scar formation inhibitor will be possible with minimal systemic exposure.

Keywords

References

  1. J. Pharm. Sci. v.74 Methods for in vitro percutaneous absorption studies V: Permeation through damaged skin Bronaugh,R.L.;Stewart,R.F.
  2. J. Pharm. Sci. v.73 Concentration-dependent enhancement of 1-dodecylaza cycloheptan-2-one on the percutaneous penetration kinetics of triamcinolone acetonide Chow,D.S.L.;Kaka,I.;Wang,T.I.
  3. Pharm. Research v.9 Polyalkylcyano acrylate nano-particles as polymeric carriers for antisense oligonucleotides Chavany,C.;Doan,T.L.;Couvreur,P.;Puisieux,F.;Helene,C.
  4. Nature v.316 Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells Derynck,R.;Jerrett,J.A.;Chen,E.Y.;Eaton,D.H.;Bell,J.R.;Assoian,R.K.;Roberts,A.B.;Sporn,M.B.;Goeddel,D.V.
  5. Proc. Natl. Acad. Sci. USA v.82 Sequence-specific cleavage of single-stranded DNA: oligodeoxynucleotide-EDTA. Fe(Ⅱ) Dreyer,G.B.;Derban,P.B.
  6. Gene v.72 Antiviral activity of conjugates between poly(I-lysine) and synthetic oligodeoxyribonucleotides Leonetii,J.P.;Rayner,B.;Lemaitre,M.;Gagnor,C.;Milhaud,P.G.;Imbach,J.L.;Lebleu,B.
  7. Bioconjugate Chem. v.1 Biogogical activity of oligonucleotide-poly(L-lysine) conjugates mechanism of cell uptake Leonetti,J.P.;Degols,G.;Lebleu,B.
  8. Proc. Natl. Acad. Sci. USA v.86 Cholesteryl-conjugated oligonucleotides: synthesis, properties, and activity as inhibitors of replication of human immuno deficiency virus in cell culture Letsinger,R.L.;Zhang,G.;Sun,D.K.;Ikeuchi,T.;Sarin,P.S.
  9. Hepatol. v.18 Lactosylated Polylysine: a new tool for targeted gene delivery [Abstract] Martinez-Fong,D.;Mullerman,I.E.;Purchio,A.F.;Borunnda,J.A.;Henandez,A.M.
  10. Int. J. Pharm. v.107 Percutaneous penetration of methyl phosphonate antisense oligonucleotides Nolen III,H.W.;Catz,P.;Friend,D.R.
  11. Proc. Natl. Acad. Sci. USA v.75 Conjugation of methotrexate to poly(L-lysine) increases drug transport and overcoming drug resistance in cultured cells Ryser,H.J.P.;Shen,W.C.
  12. DNA v.6 Cloning and sequence analysis of simian transforming growth factor-β cDNA Sharples,K.;Plowman,G.D.;Rose,T.M.;Twardzik,D.R.;Purchio,A.F.
  13. Nucleic Acids Research v.19 Modified deoxyoligo nucleotides stable to exonuclease degradation in serum Shaw,J.P.;Kent,K.;Bird,J.;Fishback,J.;Froehler,B.
  14. Nature v.359 Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo Simons,M.;Edelman,E.R.;DeKeyser.J.L.;Langer,R.;Rosenberg,R.D.
  15. Gene v.72 Phosphorothioate and normal oligodeoxyribonu-cleotides with 5'-linked acridine: characterization and preliminary kinetics of cellular uptake Stein,C.A.;Mori,K.;Loke,S.L.;Neckers,L.M.
  16. Chemical Reviews v.90 Antisense oligonucleotides: A new therapeutic principle Uhlman,E.;Peyman,A.
  17. Int. J. Pharm. v.45 Effect of sodium salicylate on in vitro percutaneous penetration of isopropamide iodide through mouse skin Yong,C.S.;Shim,C.K.;Lee,M.H.;Kim,S.K.